-
-
-
-
-
-
-
Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER
-
-
-
-
-
-
-
Pain Therapeutics (PTIE) REMOXY NDA Accepted by FDA, Sets August 7 PDUFA Date
-
-
-
-
-
-
-
Pain Therapeutics Resubmits New Drug Application for REMOXY® ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain
-
-
-
-
-
-
-
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY®
-
-
-
-
-
-
-
After-Hours Stock Movers 04/12: (RPRX) (ACUR) (MDVN) Higher; (RICE) (VRX) Lower (more...)
-
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

